Buradasınız

Anasayfa » Content

Febril Nötropenik Hastalarda Piperasilin-Tazobaktam-Amikasin Ve Meropenem-Amikasin Etkinliklerinin Karşılaştırılması

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2002

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
In patients with febrile neutropenia unless proved otherwise, infections should be considered as the cause of fever and antibiotic treatment must be started immediately. This study was designed to compare efficiency of empirically given piperaciline tazobactam+amikacin and meropenem+amikacin combinations in patients with FN. 51 patients followed and treated by Turgut Özal Medical Center, Department of Haematology were admitted to study. As a conclusion, two combinations were found to be equal in efficacy.
Bookmark/Search this post with
Abstract (Original Language): 
Febril nötrepeni (FN) hastalarında ateşin varlığı aksi ispat edilinceye kadar enfeksiyon kaynaklı olduğu kabul edilip ampirik antibiyotik tedavisine hemen başlanılması gerekmektedir. Bu çalışma, FN hastalarında ampirik piperasilin-tazobaktam+amikasin ile meropenem+amikasin tedavisinin etkinliklerinin karşılaştırmak amacıyla planlanmıştır. Çalışmaya kliniğimizde takip edilen 51 hasta ve bu hastalarda gelişen 76 FN atağı değerlendirmeye alındı. FN atağı gelişen 40 hastaya ampirik meropenem+amikasin kombinasyonu, 36 hastaya tazobaktam+amikasin kombinasyonu verildi. Çalışma sonucunda her iki kombinasyon eşit etkinlikte bulunmuştur.
FULL TEXT (PDF): 
PDF icon arastirmax-febril-notropenik-hastalarda-piperasilin-tazobaktam-amikasin-meropenem-amikasin-etkinliklerinin-karsilastirilmasi.pdf
  • 3
195-197
  • Turkish

REFERENCES

References: 

1. Kinnunen U, Syrjala H, Koskela M et al. Continuous-monitoring blood culture screening system improves the detection of bacteremia in neutropenic patients. Scand J Infect Dis 1996; 28: 287-92.
2. Rintala E. Incidence and clinical significance of positive blood cultures in febrile Episodes of patients with hematological malignancies Scand J Infect Dis 1994; 26(1):77-84.
3. Cometta A, Calandra T, Gaya H, Zinner SH, de Bock R, Del Favero A, at al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and treantment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto Infection Program. Antimicreb Agents Chemother 1996 May;40(5):1108-15.
4. Lindblad R, Rodjer S, Adriansson M, et al. Empiric monotherapy for febrile neutropenia-a randomized study comparing meropenem with ceftazidime. Scand J Infect Dis 1998;30(3):237-43.
5. Feld R, De Pauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized,, double-blind trial. J Clin Oncol 200 Nov1;18(21):3690-8.
6. Vandercam B, Gerain J, Humblet Y, Ferrant A, Wauters G, Moreau M, et al. Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic
cancer patients. Ann Hematol 2000 Mar;79(3):152-7.
7. Shah PM, Heller A, Fuhr HG, Walter F, Halir S, Schamann R, et al. Empirical
monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients. Infection 1996 Nov-Dec;24(6):480-4.
8. Marie JP, Vekhoff A, Cony-Makhoul P, Fiere D, Guy H, Herbrecht R, et al.
Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in
patients with neutropenia and fever. Presse Med 1995 Feb25;24(8):397-401.
9. Marie JP, Marjanovic Z, Vekhoff A, Bouvet A, Chast F, Levy V, et al.
Piperacilline/tazobactam plus tobramycin versus ceftazidim plus tobramycin as empiric therapy for fever in severely neutrupenic patients. Support Care Cancer 1999
Mar:7(2):89-94.
10. Figuera A, Rivero N, Pajuelo F, Font P, Leyra F, de La Camara R, et al. Inıtial empiric therapy of febrile neutropenia with antibiotic monotherapy. Med Clin (Barc) 2001
May 5;116(16):610-1.
11. Del Favero A, Menichetti F, Martino P, Bucaneve G, Micozzi A, Gentile G, et al. A
multicenter double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia. Clin Infect Dis

Thank you for copying data from http://www.arastirmax.com